#Cohortstudy #Epidemiology #InfectiousDisease #Lassafever #Publichealth
#Cohortstudy #Epidemiology #InfectiousDisease #Lassafever #Publichealth
h…
#Cohortstudy #Epidemiology #InfectiousDisease #Lassafever #Publichealth
#Cohortstudy #Epidemiology #InfectiousDisease #Lassafever #Publichealth
h…
A recent article by Emory University experts highlights the value of knowing workplace exposure history.
Read: https://ow.ly/JtCo50ZWsNQ
#LassaFever #NETEC
A recent article by Emory University experts highlights the value of knowing workplace exposure history.
Read: https://ow.ly/JtCo50ZWsNQ
#LassaFever #NETEC
This review highlights emerging #antivirals and #MonoclonalAntibodies, emphasizing stage-specific combination therapy as a promising strategy to improve outcomes.
#OpenAccess #DIT_Journal: doi.org/10.1016/j.dc...
This review highlights emerging #antivirals and #MonoclonalAntibodies, emphasizing stage-specific combination therapy as a promising strategy to improve outcomes.
#OpenAccess #DIT_Journal: doi.org/10.1016/j.dc...
#Nigeria #LassaFever
www.premiumtimesng.com/news/916572-...
#Nigeria #LassaFever
www.premiumtimesng.com/news/916572-...
What are the clinical and epidemiological dynamics behind this critical tropical disease?
#LassaFever #GlobalHealth
What are the clinical and epidemiological dynamics behind this critical tropical disease?
#LassaFever #GlobalHealth
#Clinicalresearch #Lassafever #Vaccinetrials #Viralhemorrhagicfever #WestAfrica
#Clinicalresearch #Lassafever #Vaccinetrials #Viralhemorrhagi…
#Clinicalresearch #Lassafever #Vaccinetrials #Viralhemorrhagicfever #WestAfrica
#Clinicalresearch #Lassafever #Vaccinetrials #Viralhemorrhagi…
Live map → enclai.net/map
#Epidemiology #GlobalHealth #IDsky #LassaFever #Nigeria
Live map → enclai.net/map
#Epidemiology #GlobalHealth #IDsky #LassaFever #Nigeria
This review highlights emerging #antivirals, #MonoclonalAntibodies, and combination therapies that could outperform ribavirin and improve stage-specific treatment.
#OpenAccess in #DIT_Journal: doi.org/10.1016/j.dc...
This review highlights emerging #antivirals, #MonoclonalAntibodies, and combination therapies that could outperform ribavirin and improve stage-specific treatment.
#OpenAccess in #DIT_Journal: doi.org/10.1016/j.dc...
"When Lassa Fever Travels: Lessons From a Nosocomial Outbreak in Guinea" academic.oup.com/jid/article/...
"When Lassa Fever Travels: Lessons From a Nosocomial Outbreak in Guinea" academic.oup.com/jid/article/...
Govt authorities blaming victims for dying.
Not a good look for Nigeria #PublicHealth #Prevention #RCCE
breakthroughactionandresearch.org/responding-t...
„NCDC said the deaths are likely due to poor health-seeking behavior among patients who seek medical intervention too late…“
Govt authorities blaming victims for dying.
Not a good look for Nigeria #PublicHealth #Prevention #RCCE
breakthroughactionandresearch.org/responding-t...
„NCDC said the deaths are likely due to poor health-seeking behavior among patients who seek medical intervention too late…“
www.nih.gov/news-events/...
www.nih.gov/news-events/...
www.sciencedirect.com/science/arti...
link.springer.com/content/pdf/...
www.sciencedirect.com/science/arti...
link.springer.com/content/pdf/...
ukhsa.blog.gov.uk/2025/03/07/w...
link.springer.com/article/10.1...
ukhsa.blog.gov.uk/2025/03/07/w...
link.springer.com/article/10.1...
theconversation.com/why-nigeria-...
#LassaFever
#TCAArchive
theconversation.com/why-nigeria-...
#LassaFever
#TCAArchive
Page et al. use wearable biosensors to monitor vital sign trends in patients with Lassa fever in Sierra Leone. Tachycardia and reduced heart rate variability associate with poor outcomes.
https://bit.ly/3Hk57tE #LassaFever #MedicalResearch
Page et al. use wearable biosensors to monitor vital sign trends in patients with Lassa fever in Sierra Leone. Tachycardia and reduced heart rate variability associate with poor outcomes.
https://bit.ly/3Hk57tE #LassaFever #MedicalResearch
Read more: buff.ly/CCtJv0M
Read more: buff.ly/CCtJv0M
This marks a 31 per cent increase in deaths compared to the same period in 2025.
How we’re responding: https://www.doctorswithoutborders.ca/nigeria-reducing-fear-improving-care-during-severe-lassa-fever-season/
This marks a 31 per cent increase in deaths compared to the same period in 2025.
How we’re responding: https://www.doctorswithoutborders.ca/nigeria-reducing-fear-improving-care-during-severe-lassa-fever-season/
(202) 224-3121
#NIH #NIAID #MedSky #PublicHealth #BiomedicalResearch #Ebola #Marburg #SARSCoV2 #COVID19 #LassaFever #HHS
(202) 224-3121
#NIH #NIAID #MedSky #PublicHealth #BiomedicalResearch #Ebola #Marburg #SARSCoV2 #COVID19 #LassaFever #HHS